Regulations.gov document
Tab 10 - Lawrence X_ Yu, Quality by Design for Orally Inhaled Drug Products, PQRI Workshop…
Supporting & Related Material · FDA-2017-P-5477 · posted Sep 6, 2017
Key facts
| Document ID | FDA-2017-P-5477-0012 |
|---|---|
| Title | Tab 10 - Lawrence X_ Yu, Quality by Design for Orally Inhaled Drug Products, PQRI Workshop on Demonstrating Bioequivalence of Loca re Citizen Petition from Hyman, Phelps & McNamara on behalf of United Therapeutics Corporation |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2017-P-5477 |
| Posted | Sep 6, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: